Table 2.
Profile of CEACAM6-positive immunostaining in various tumor tissues
| Organ | Diagnosis | N (282) | Positive N (%) |
|---|---|---|---|
| Stomach | Adenocarcinoma | 28 | 24 (86) |
| High-grade GED | 5 | 0 (0) | |
| Low-grade GED | 5 | 0 (0) | |
| Colorectum | Adenocarcinoma | 19 | 18 (95) |
| Tubular adenoma | 5 | 4 (80) | |
| Hyperplastic polyp | 5 | 4 (80) | |
| Pancreas | Adenocarcinoma | 2 | 2 (100) |
| Liver | Hepatocellular carcinoma | 17 | 6 (35) |
| Lung | Adenocarcinoma | 18 | 15 (83) |
| Squamous cell carcinoma | 20 | 12 (60) | |
| Small cell carcinoma | 20 | 0 (0) | |
| Ovary | Mucinous carcinoma | 8 | 7 (88) |
| Serous carcinoma | 6 | 1 (17) | |
| Endometrioid carcinoma | 1 | 0 (0) | |
| Clear cell carcinoma | 1 | 0 (0) | |
| Kidney | Renal cell carcinoma | 22 | 3 (14) |
| Bladder | Urothelial carcinoma | 30 | 4 (13) |
| Adenocarcinoma | 3 | 3 (100) | |
| Prostate | Adenocarcinoma | 8 | 0 (0) |
| Urethra | Adenocarcinoma | 1 | 1 (100) |
| Breast | Invasive ductal carcinoma | 9 | 1 (11) |
| Thyroid | Papillary carcinoma | 8 | 0 (0) |
| Skin | Melanoma | 4 | 0 (0) |
| Bone | Osteosarcoma | 32 | 0 (0) |
| Bone | Giant cell tumor | 5 | 0 (0) |
GED gastric epithelial dysplasia, N number of samples examined